CSIMarket
 
Atrion Corporation  (ATRI)
Other Ticker:  
 
 
Price: $436.1000 $18.05 4.318%
Day's High: $438.75 Week Perf: 0.11 %
Day's Low: $ 409.27 30 Day Perf: 29.84 %
Volume (M): 41 52 Wk High: $ 670.00
Volume (M$): $ 17,880 52 Wk Avg: $459.64
Open: $409.27 52 Wk Low: $274.98



 Market Capitalization (Millions $) 768
 Shares Outstanding (Millions) 2
 Employees 660
 Revenues (TTM) (Millions $) 169
 Net Income (TTM) (Millions $) 21
 Cash Flow (TTM) (Millions $) -26
 Capital Exp. (TTM) (Millions $) 28

Atrion Corporation
Atrion Corporation is a healthcare company that focuses on developing and manufacturing medical devices and specialty products for various clinical applications. Established in 1944, the company was initially known as Allen-Simmons Corporation and later changed its name to Atrion Corporation in 1993, following a merger with Cardiovascular Products, Inc.

With its headquarters in Allen, Texas, Atrion Corporation has a significant global presence, with various subsidiaries and facilities in Canada, Europe, and Asia. The company has a diverse range of product lines, comprising of medical devices, intraocular lenses, inertial navigation systems, and other specialty products.

The medical device business unit of Atrion Corporation designs, develops, and manufactures a wide range of cardiovascular and fluid delivery products. These include catheters, valves, sheaths, introducers, and other devices used in diagnostic and interventional procedures. These devices offer healthcare professionals precise control and improved outcomes, making them the preferred choice in many clinical settings.

Additionally, Atrion Corporation's intraocular lens business unit focuses on the design and manufacturing of lenses used in cataract surgery. The lenses are made from high-quality materials that provide excellent optical clarity and patient comfort, leading to improved visual outcomes.

Another interesting aspect of Atrion Corporation's product line is its inertial navigation systems, which are used in the aerospace and defense industry. These systems are designed to provide accurate guidance and navigation information, making them critical components in various applications, including missile guidance, unmanned aerial systems, and spacecraft.

In terms of financials, Atrion Corporation generates revenues of approximately $155 million annually, with a net income of $38 million. The company is publicly traded on the NASDAQ stock exchange under the symbol "ATRI," and it has a market capitalization of approximately $1 billion.

Overall, Atrion Corporation is a healthcare company that has shown resilience and innovation, particularly in its medical device and intraocular lens product lines. Its dedication to precision, quality, and improved outcomes has made it a trusted name in the healthcare industry, positioning the company for continued growth and success.


   Company Address: One Allentown Parkway Allen 75002 TX
   Company Phone Number: 390-9800   Stock Exchange / Ticker: NASDAQ ATRI
    Next quarterly dividend pay out on March 29, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Dividend

Atrion Corporation Announces Quarterly Dividend Amidst Market Volatility

Published Tue, Feb 27 2024 6:21 PM UTC



In a press release issued today, Atrion Corporation (NASDAQ: ATRI) revealed the declaration of a quarterly cash dividend of $2.20 per share on its outstanding shares of Common Stock. The dividend is scheduled to be paid on March 29, 2024, to stockholders of record as of March 15, 2024. Atrion Corporation, a leading medical device manufacturer headquartered in Allen...

Atrion Corporation

ATRI Faces Sharp Decline in EPS, But Remains Optimistic amid Market Challenges in Q3 2023

The stock market has seen its fair share of ups and downs, but in the third quarter of 2023, Atrion Corporation faced some challenges. Despite this, there are still key aspects to be optimistic about.
During this earnings season, Atrion Corporation experienced a revenue decrease of -6.094% to $41.91 million. While this may seem concerning at first glance, it's important to note that the overall Medical Equipment & Supplies industry recorded a revenue rise during the same period. This indicates that Atrion Corporation's performance is in line with industry trends.

Atrion Corporation

Atrion Corporation Records Significant Decline in Revenue During Latest Fiscal Period



Atrion Corporation, a prominent company specializing in medical equipment and supplies, recently disclosed its financial results for the fiscal period ending June 30, 2023. Unfortunately, the company experienced a decline in both its top and bottom-line performance compared to the previous year. This article aims to analyze the financial data in order to shed light on the challenges faced by Atrion Corporation and provide context to its recent stock performance.
Soft Top and Bottom-Line Results:
During the fiscal year ending June 30, 2023, Atrion Corporation reported a notable decline in both revenue and earnings per share (EPS). Revenue dropped by -10.319% year on year, amounting to $43.84 million. To put it into perspective, EPS plummeted by -28.27% to $3.73 compared to $5.20 in the second quarter of 2022.

Atrion Corporation

Atrion Corporation's EPS Plunges in Recent Fiscal Period due to Sluggish Sales

Investing in the stock market involves managing risks, and careful consideration of company financials is essential in making well-informed investment decisions. The recent financial results of Atrion Corporation should serve as a warning to investors considering putting their money into this company.
In the first quarter of 2023, Atrion Corporation reported significant drops in their top and bottom-line figures, with EPS plummeting by -57.96% and revenue by -15.158% year on year. Such a downward trend in key financial metrics spells trouble for the company, and as investors, one must proceed with caution.






 

Atrion's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com